Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 17/20 | 0.65 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.60 |
| ▸ | CDK2 | P24941 | 3/20 | 0.60 |
| ▸ | CCNK | O75909 | 2/20 | 0.60 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.60 |
| ▸ | CCR7 | P32248 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25079785 | 1.00 | CCR6 (0.65) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL25079907 | 0.90 | CCR6 (0.52) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL30284931 | 0.89 | CCR6 (0.69) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL25079712 | 0.89 | CCR6 (0.69) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL30284815 | 0.89 | CCR6 (0.69) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL25079894 | 0.89 | CCR6 (0.69) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL25079898 | 0.88 | CCR6 (0.68) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL26461196 | 0.88 | CCR6 (0.60) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL26465350 | 0.87 | CCR6 (0.70) | CCR6CCNA2CDK2CCNKCDK12 | |
| SCHEMBL25079818 | 0.86 | CCR6 (0.65) | CCR6CCNA2CDK2CCNKCDK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4387965-A2 | ARYL SULFONYL COMPOUNDS AS CCR6 INHIBITORS | ChemoCentryx, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| WO-2023023534-A2 | ARYL SULFONYL COMPOUNDS AS CCR6 INHIBITORS | CHEMOCENTRYX, INC. (US) | 2023-02-23 | — | — | WO | disclosed |